CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — Revenue by Fiscal Year
18 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9ba44d7b-86b3-41ef-b3ec-5df837ae8f74/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $4.0B | 2024-12-29 – 2025-12-27 | evidence 0001100682-26-000022 |
| FY 2024 | $4.0B | 2023-12-31 – 2024-12-28 | evidence 0001100682-25-000011 |
| FY 2023 | $4.1B | 2023-01-01 – 2023-12-30 | evidence 0001100682-24-000007 |
| FY 2022 | $4.0B | 2021-12-26 – 2022-12-31 | evidence 0001100682-23-000006 |
| FY 2021 | $3.5B | 2020-12-27 – 2021-12-25 | evidence 0001100682-22-000007 |
| FY 2020 | $2.9B | 2019-12-29 – 2020-12-26 | evidence 0001100682-21-000005 |
| FY 2019 | $2.6B | 2018-12-30 – 2019-12-28 | evidence 0001100682-20-000005 |
| FY 2018 | $2.3B | 2017-12-31 – 2018-12-29 | evidence 0001100682-19-000004 |
| FY 2017 | $1.9B | 2017-01-01 – 2017-12-30 | evidence 0001100682-19-000004 |
| FY 2016 | $1.7B | 2015-12-27 – 2016-12-31 | evidence 0001100682-19-000004 |
| FY 2015 | $1.4B | 2014-12-28 – 2015-12-26 | evidence 0001100682-16-000006 |
| FY 2014 | $1.3B | 2013-12-29 – 2014-12-27 | evidence 0001628280-15-000785 |
| FY 2013 | $1.2B | 2012-12-30 – 2013-12-28 | evidence 0001445305-14-000599 |
| FY 2012 | $1.1B | 2012-01-01 – 2012-12-29 | evidence 0001445305-13-000358 |
| FY 2011 | $1.1B | 2010-12-26 – 2011-12-31 | evidence 0001518519-12-000030 |
| FY 2010 | $1.1B | 2009-12-27 – 2010-12-25 | evidence 0001047469-11-001182 |
| FY 2009 | $1.2B | 2008-12-28 – 2009-12-26 | evidence 0001047469-11-001182 |
| FY 2008 | $1.3B | 2007-12-30 – 2008-12-27 | evidence 0001047469-11-001182 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — all facts · Net Income · Operating Income